John H Johnson, OD | |
156 No Main St, St Albans, VT 05478 | |
(802) 524-3933 | |
(802) 524-2023 |
Full Name | John H Johnson |
---|---|
Gender | Male |
Speciality | Optometry |
Experience | 43 Years |
Location | 156 No Main St, St Albans, Vermont |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700982410 | NPI | - | NPPES |
8368 | Other | BCBS | |
59V013 | Other | MVP | |
1345070001 | Other | DMERCA | |
1000101 | Medicaid | VT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 0300000200 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
John H Johnson, OD 156 No Main St, St Albans, VT 05478 Ph: (802) 524-3933 | John H Johnson, OD 156 No Main St, St Albans, VT 05478 Ph: (802) 524-3933 |
News Archive
HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that the pharmaceutical industry stands to gain from the patient-centered medical home concept that continues to gain traction across the country. According to the recent New England Health Plan Analysis, medical home projects seek to maintain costs and improve health through better treatment compliance, including prescription drug regimens.
Molecular and serum markers of prognosis in renal cell carcinoma have remained elusive. In large part, tumor (TNM) stage, Fuhrman grade, and patient performance status have stood the test of time as the most valuable factors in predicting patient outcome following surgery.
Each year more than 1.7 million people in the United States sustain a traumatic brain injury (TBI). The incidence of TBI in older adults poses special diagnostic, management and treatment challenges, say experts in a special collection of papers on TBI in the elderly in NeuroRehabilitation: An Interdisciplinary Journal.
Vertex Pharmaceuticals Incorporated today announced new data from an interim analysis of the exploratory global Phase 3b CONCISE study evaluating the potential to shorten total treatment with telaprevir combination therapy to 12 weeks in certain people with genotype 1 chronic hepatitis C virus infection who have the IL28B CC genotype.
Albireo today announced the completion of a phase 1b study showing a favorable tolerability and safety profile of A3309 in patients with chronic idiopathic constipation. In addition, the data revealed appropriate efficacy signals in this patient population. A3309 is a first in class compound developed for the treatment of chronic idiopathic constipation and constipation-predominant Irritable Bowel Syndrome (IBS-C).
› Verified 6 days ago
Dr. Steven John St. Marie, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 128 Fisher Pond Rd, St Albans, VT 05478 Phone: 802-524-9561 Fax: 802-524-6060 | |
Dr. Carl Edward Whitehouse, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 50 Bank St, St Albans, VT 05478 Phone: 802-524-9561 Fax: 802-524-6060 |